» Articles » PMID: 25653188

Cervical Cancer Screening with Clinic-based Pap Test Versus Home HPV Test Among Somali Immigrant Women in Minnesota: a Pilot Randomized Controlled Trial

Overview
Journal Cancer Med
Specialty Oncology
Date 2015 Feb 6
PMID 25653188
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Cervical cancer is more common in the Somali immigrant population than the general population in the United States (US). There are low rates of cervical cancer screening among Somali women. This study compares cervical cancer screening test completion rates for a home human papilloma virus (HPV) test and standard clinic Pap test. Sixty-three Somali immigrant women aged 30-70 years who had not undergone cervical cancer screening within the past 3 years were randomly assigned to a home HPV test group (intervention) or a clinic Pap test group (control). Test completion rates were measured at 3 months. Univariate and multivariate logistic regression models were used to explore factors associated with test completion (intention-to-treat analysis). Participants in the HPV test group were 14 times more likely to complete the test compared to those in the Pap test group (P = 0.0002). Women who reported having friends/family members to talk about cancer screening were approximately three times more likely to complete any screening test than those who did not (P = 0.127) and participants who reported residing in the US longer were more likely to complete a screening test (P = 0.011). Future research should explore the potential of using the home-based HPV test kits as an initial approach to cervical cancer screening.

Impact: The use of a self-sampling HPV kit has the potential to increase cervical cancer screening in under-served communities in the US.

Citing Articles

Disparities in Cancer Screening Among the Foreign-Born Population in the United States: A Narrative Review.

Rosowicz A, Hewitt D Cancers (Basel). 2025; 17(4).

PMID: 40002170 PMC: 11852454. DOI: 10.3390/cancers17040576.


HPV self-sampling implementation strategies to engage under screened communities in cervical cancer screening: a scoping review to inform screening programs.

Fullerton M, Ford C, DSilva C, Chiang B, Onobrakpor S, Dievert H Front Public Health. 2024; 12:1430968.

PMID: 39257941 PMC: 11384595. DOI: 10.3389/fpubh.2024.1430968.


Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review.

Mackay O, Lifford K, Kalra A, Williams D J Med Screen. 2024; 32(1):2-18.

PMID: 39212004 PMC: 11869506. DOI: 10.1177/09691413241274312.


Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening.

Lordelo M, Oliveira C, Aguirre Buexm L, Reis R, Longatto-Filho A, Possati-Resende J PLoS One. 2024; 19(8):e0306130.

PMID: 39121102 PMC: 11315343. DOI: 10.1371/journal.pone.0306130.


Transition, Adjustment, and Healthcare Avoidance: African Immigrant Women's Experiences and Perceptions of Navigating Primary Healthcare in the USA.

Tefera G, Yu M, Robinson E, Winter V, Bloom T Healthcare (Basel). 2024; 12(15).

PMID: 39120207 PMC: 11311796. DOI: 10.3390/healthcare12151504.


References
1.
Swan J, Breen N, Graubard B, McNeel T, Blackman D, Tangka F . Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010; 116(20):4872-81. PMC: 2950901. DOI: 10.1002/cncr.25215. View

2.
Johnson C, Mues K, Mayne S, Kiblawi A . Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis. 2008; 12(3):232-41. DOI: 10.1097/LGT.0b013e31815d8d88. View

3.
Swan J, Breen N, Coates R, Rimer B, Lee N . Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003; 97(6):1528-40. DOI: 10.1002/cncr.11208. View

4.
Vijayaraghavan A, Efrusy M, Lindeque G, Dreyer G, Santas C . Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa. Gynecol Oncol. 2008; 112(2):377-83. DOI: 10.1016/j.ygyno.2008.08.030. View

5.
Sankaranarayanan R, Nene B, Shastri S, Jayant K, Muwonge R, Budukh A . HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-94. DOI: 10.1056/NEJMoa0808516. View